Cosomil, Inc. Their mission is to contribute to the early detection of diseases and support pharmaceutical development using their unique 1-molecule measurement imaging technology. In terms of their products and services, Cosomil, Inc.

They have developed a proprietary 1-molecule measurement liquid biopsy technique that allows for the evaluation of various enzyme activities in the blood, enabling advanced testing capabilities. Additionally, they offer support for the development of diagnostic drugs and pharmaceutical products for early disease detection. Cosomil, Inc.

They aim to make a valuable contribution to the advancement of healthcare, where everyone can live their lives without the burden of disease. Their vision encompasses a future where diseases are detected early, tailored effective treatments are available for each individual, and the world is free from the worries of illnesses. With a team of dedicated experts, including leaders with Ph.

D. Established in April 2022, Cosomil, Inc. Their brand is synonymous with excellence in enzyme activity measurement imaging, with a focus on early disease detection and pharmaceutical development support